-
Reply: Sirolimus- vs Paclitaxel-Coated Balloons: It Is Only the Start JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Patrick W. Serruys MD PhD, Kai Ninomiya MD, Yoshinobu Onuma MD PhD
-
Tricuspid Transcatheter Orthotopic and Heterotopic Replacement Screening F.A.I.L.: First Attempt In Learning! JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Alessandro Sticchi MD, Marco De Carlo MD
-
ANOCA and the Endothelium: A Link That Can NO Longer Be Ignored JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Thabo Mahendiran BMBCh MD, Bernard De Bruyne MD PhD
-
Sirolimus- vs Paclitaxel-Coated Balloons: It Is Only the Start JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Anton Camaj MD MS, Pier Pasquale Leone MD MSc, Annapoorna Kini MD, Samin K. Sharma MD
-
Dissecting the Fall From Grace of Antegrade Dissection Re-Entry Techniques in Chronic Total Occlusion PCI JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Ashish Pershad MD MS
-
Clinical Characteristics and Outcomes of Patients Screened for Transcatheter Tricuspid Valve Replacement: The TriACT Registry JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Daniel Hagemeyer MD, Anas Merdad MD, Laura Villegas Sierra MD, Andrea Ruberti MD, Faraj Kargoli MD, Marine Bouchat MD, Mauro Boiago MD, Aris Moschovitis MD, Djeven P. Deva MD, Lukas Stolz MD, Geraldine Ong MD MSc, Mark D. Peterson MD PhD, Nicolo Piazza MD, Maurizio Taramasso MD, Nicolas Dumonteil MD, Thomas Modine MD, Azeem Latib MD, Fabien Praz MD, Jörg Hausleiter MD, Neil P. Fam MD MSc
Transcatheter tricuspid valve replacement (TTVR) abolishes tricuspid regurgitation (TR) and has emerged as a definitive treatment for TR. The purpose of this multicenter, observational study was to determine the clinical characteristics and short-term outcomes of patients with TR screened for TTVR. Patients underwent TTVR screening at 7 centers on a compassionate-use basis. The primary endpoints were
-
Mitral Transcatheter Edge-to-Edge Repair: Bridging the Gap Between Clinical Trials and Real-World JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Andrea Scotti MD, Azeem Latib MD
-
Coronary Vasomotor Dysfunction Is Associated With Cardiovascular Events in Patients With Nonobstructive Coronary Artery Disease JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Yoshihisa Kanaji MD PhD, Ali Ahmad MD, Sara Jaskanwal Deep Singh MBChB, Ilke Ozcan MD, Nadia Akhiyat MD MS, Abhiram Prasad MD PhD, Claire E. Raphael MBBS PhD, Tsunekazu Kakuta MD PhD, Lilach O. Lerman MD PhD, Amir Lerman MD
Coronary vasomotor dysfunction (CVDys) can be comprehensively classified on the basis of anatomy and functional mechanisms. The aim of this study was to evaluate the association between different CVDys phenotypes and outcomes in patients with angina and nonobstructive coronary artery disease (ANOCA). Patients with ANOCA who underwent coronary reactivity testing using an intracoronary Doppler guidewire
-
Generalizing Tricuspid Clinical Trial Results to the “Real World” JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Mackram F. Eleid MD
-
Association Between Clinical Trial Participation Status and Outcomes With Mitral Transcatheter Edge-to-Edge Repair JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Amro Aglan MD, Ahmed Maraey MD, Ayman R. Fath MD, Hadeer Elsharnoby MD, Wael Abdelmottaleb MD MSc, Ahmed M. Elzanaty MD MPH, Mahmoud Khalil MD, Sourbha S. Dani MD MSc, Marwan Saad MD PhD, Islam Y. Elgendy MD
Clinical trials have demonstrated the efficacy and safety of mitral transcatheter edge-to-edge repair (M-TEER) for selected patients with severe mitral regurgitation. However, the generalizability of trial results to real-world patients remains uncertain. The authors aimed to compare baseline characteristics and in-hospital outcomes among trial participants with nonparticipants undergoing M-TEER. Using
-
A Prospective, Multicenter, Real-World Registry of Coronary Lithotripsy in Calcified Coronary Arteries JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Oriol Rodriguez-Leor, Ana Belen Cid-Alvarez, Maria Lopez-Benito, Nieves Gonzalo, Victoria Vilalta, Jose Antonio Diarte de Miguel, Leticia Fernandez López, Alfonso Jurado-Roman, Alejandro Diego, Juan Francisco Oteo, Carlos Cuellas, Ramiro Trillo, Alejandro Travieso, Fernando Alfonso, Xavier Carrillo, José Miguel Vegas-Valle, Carlos Cortes-Villar, Isaac Pascual, Juan Francisco Muñoz Camacho, Xacobe Flores
-
Real-World Experience of Transcatheter Mitral Valve Replacement JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Syed Zaid, Gilbert H.L. Tang
-
Transapical Mitral Valve Replacement JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Michaela M. Hell, Mirjam G. Wild, Stephan Baldus, Tanja Rudolph, Hendrik Treede, Anna Sonia Petronio, Thomas Modine, Martin Andreas, Augustin Coisne, Alison Duncan, Luis Nombela Franco, Fabien Praz, Hendrik Ruge, Lenard Conradi, Andreas Zierer, Amedeo Anselmi, Nicolas Dumonteil, Georg Nickenig, Miguel Piñón, Sebastian Barth, Marianna Adamo, Christophe Dubois, Lucia Torracca, Francesco Maisano, Philipp
-
Bridging the Gap JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Alec Vishnevsky, David L. Fischman
-
Fate of Box Fracture of Calcified Plaque After Intravascular Lithotripsy JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Yuki Katagiri, Akihiro Tobe, Seiji Yamazaki, Yoshinobu Onuma, Patrick W. Serruys, Shigeru Saito
-
A Phantom Echocardiographic Figure-of-Eight Image From Disc-Structured Occluder Can Be Artifactual and Truly Ominous JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Lanqi Hua, Sheetal Patel, Kellie Glover, Ruihai Zhou
-
Coronary Stent Placement-Induced Intramural Hematoma of the Interventricular Septum JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Junwen Wang, Xin Wei, Yuan Feng, Yong Peng
-
Fractional Flow Reserve–Guided Drug-Coated Balloon vs Drug-Eluting Stent for de Novo Non-Small Coronary Lesions JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Delong Chen, Abuduwufuer Yidilisi, Yuxuan Zhang, Jiacheng Fang, Yiyue Zheng, Feng Gao, Weiming Li, Hao Zhou, Yan Chen, Dongsheng Lu, Jian'an Wang, Jun Jiang
-
A Partial-Demembrane Method to Protect the Aberrant Right Subclavian Artery in Coarctation of the Aorta JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Ruitao Li, Xiang Li, Qiao Li, Yuan Feng
-
Between a Rock and a Hard Place JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Michael P. Savage, David L. Fischman, Mamas A. Mamas
-
Reply JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Chetan P. Huded, Suzanne V. Arnold, David J. Cohen, Adnan K. Chhatriwalla, John A. Spertus
-
Non–Vitamin K Antagonist Versus Vitamin K Antagonist Oral Anticoagulant Agents After Transcatheter Aortic Valve Replacement JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Bashir Alaour, Enrico Ferrari, Dik Heg, David Tueller, Thomas Pilgrim, Olivier Muller, Stephane Noble, Raban Jeger, Oliver Reuthebuch, Stefan Toggweiler, Christian Templin, Peter Wenaweser, Fabian Nietlispach, Maurizio Taramasso, Christoph Huber, Marco Roffi, Stephan Windecker, Stefan Stortecky
-
Decoding Ticagrelor Dyspnea JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Alberto Giannoni, Claudio Passino, Francesco Gentile, Paolo Sciarrone, Michele Emdin
-
P2Y12 Inhibitors in Chronic Coronary Syndromes Undergoing Elective PCI JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 José Luis Ferreiro
-
Left Atrial Appendage Occlusion JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Apostolos Tzikas
-
National Variability in Pacemaker Implantation Rate Following TAVR JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Amit N. Vora, Hemal Gada, Pratik Manandhar, Andrezej Kosinski, Ajay Kirtane, Tamim Nazif, Michael Reardon, Susheel Kodali, David J. Cohen, Vinod Thourani, Matthew Sherwood, Howard Julien, Sreekanth Vemulapalli
-
Amulet Occluder Implantation in Patients With Failed Prior Left Atrial Appendage Occlusion JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Mohamad Alkhouli, Akash Makkar, James V. Freeman, Christopher R. Ellis, Atman P. Shah, Hemal Gada, Megan Coylewright, Monica Lo, Himanshu Agarwal, Dhanunjaya Lakkireddy
-
Pacemaker Implantation Rate Following TAVR JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 François Philippon
-
-
Reply JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Dominick J. Angiolillo, Davide Cao, Usman Baber, Roxana Mehran
-
Impact of Bleeding Risk and Inflammation on Cardiovascular Outcomes After Percutaneous Coronary Intervention JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Manish Vinayak, Davide Cao, Richard Tanner, Anoop N. Koshy, Serdar Farhan, Birgit Vogel, Samantha Sartori, Yihan Feng, Vishal Dhulipala, Ayush Arora, George D. Dangas, Annapoorna S. Kini, Samin K. Sharma, Roxana Mehran
-
3D-ICE–Guided Repair of a Persistent LVOT Pseudoaneurysm After Aortic Valve Replacement JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Abdullah Al-Abcha, Juan Crestanello, Mohamad Alkhouli
-
Inflammatory Potential and Risk Prediction After PCI in High Bleeding Risk Patients JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Usman Baber
-
Distal Radial Access Evolution JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Gregory A. Sgueglia
-
-
Transcatheter Aortic Valve Replacement in Asymptomatic Severe Aortic Stenosis JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Kyriakos Dimitriadis, Nikolaos Pyrpyris, Konstantina Aggeli, Konstantinos Tsioufis
-
Ticagrelor vs Clopidogrel for Complex Percutaneous Coronary Intervention in Chronic Coronary Syndrome JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Benoit Lattuca, Cedric Mazeau, Guillaume Cayla, Grégory Ducrocq, Paul Guedeney, Mikael Laredo, Raphaëlle Dumaine, Mohamad El Kasty, Petr Kala, Mohammed Nejjari, Ota Hlinomaz, Olivier Morel, Olivier Varenne, Florence Leclercq, Laurent Payot, Christian Spaulding, Farzin Beygui, Grégoire Rangé, Zuzana Motovska, Jean-Jacques Portal, Eric Vicaut, Jean-Philippe Collet, Gilles Montalescot, Johanne Silvain
-
Distal Radial Access for Coronary Procedures in a Large Prospective Multicenter Registry JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Jun-Won Lee, Yongcheol Kim, Bong-Ki Lee, Sang-Yong Yoo, Sang Yeub Lee, Chan Joon Kim, Han-Young Jin, Jin Sup Park, Jung Ho Heo, Do Hoi Kim, Jin Bae Lee, Dong-Kie Kim, Jun Ho Bae, Sung-Yun Lee, Seung-Hwan Lee
-
What Oral Anticoagulant Is Best After TAVR JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Jurriën M. ten Berg, Daniël C. Overduin, Dirk-Jan van Ginkel
-
Should We Stent Vulnerable, But Asymptomatic, Lesions? JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-07 Nils P. Johnson MD MS, K. Lance Gould MD, Jagat Narula MD PhD
-
Presence and Relevance of Myocardial Bridge in LAD-PCI of CTO and Non-CTO Lesions JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-07 Kei Yamamoto MD, Yoichiro Sugizaki MD, Dimitri Karmpaliotis MD PhD, Takao Sato MD, Mitsuaki Matsumura BS, Shuro Narui MD, Myong Hwa Yamamoto MD, Khady N. Fall MD MPH, Elizabeth I. James BS, John B. Glinski BS, Maya L. Rabban BA, Megha Prasad MD MS, Vivian G. Ng MD, Sanjum S. Sethi MD, Tamim M. Nazif MD, Sahil A. Parikh MD, Torsten P. Vahl MD, Ziad A. Ali MD DPhil, LeRoy E. Rabbani MD, Michael B. Collins
Intravascular ultrasound (IVUS) studies show that one-quarter of left anterior descending (LAD) arteries have a myocardial bridge. An MB may be associated with stent failure when the stent extends into the MB. The aim of this study was to investigate: 1) the association between an MB and chronic total occlusion (CTO) in any LAD lesions; and 2) the association between an MB and subsequent clinical outcomes
-
-
Commissural Alignment and Transcatheter Aortic Valve Performance JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-07 Ole De Backer, Alejandro Travieso, Nicholas Montarello, Matthias Renker, Gabriela Tirado-Conte, Lucca Loretz, Efstratios I. Charitos, Stefan Toggweiler, Won-Keun Kim
-
Percutaneous Coronary Intervention of Left Anterior Descending Chronic Total Occlusion: Watch Out for Myocardial Bridging! JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-07 Lorenzo Azzalini MD PhD MSc, Marouane Boukhris MD
-
Universal Mastery in Valve Disease Treatment: Myth or Attainable Goal? JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-07 Mohamad Alkhouli MD, Juan A. Crestanello MD, Charanjit S. Rihal MD
-
National Variation in Hospital MTEER Outcomes and Correlation With TAVR Outcomes: STS/ACC TVT Registry Analysis JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-07 Dharam J. Kumbhani MD SM, Pratik Manandhar MS, Anthony A. Bavry MD MPH, Adnan K. Chhatriwalla MD, Jay Giri MD, Michael Mack MD, John Carroll MD, Ambarish Pandey MD MSc, Andrzej Kosinski PhD, Eric D. Peterson MD MPH, Tsuyoshi Kaneko MD, James A. de Lemos MD, Sreekanth Vemulapalli MD
A single, multitiered valve center designation has been proposed to publicly identify centers with expertise for all valve therapies. The correlation between transcatheter aortic valve replacement (TAVR) and mitral transcatheter edge-to-edge repair (MTEER) procedures is unknown. The authors sought to examine the relationship between site-level volumes and outcomes for TAVR and MTEER. We further explored
-
Transcatheter Tricuspid Valve Replacement With the Cardiovalve System JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-07 Neil P. Fam MD MSc, Geraldine Ong MD MSc, Rodrigo Estevez-Loureiro MD, Christian Frerker MD, Francesco Bedogni MD, Angel Sanchez-Recalde MD, Sergio Berti MD, Rimantas Benetis MD, Georg Nickenig MD, Mark D. Peterson MD PhD, Francesco Maisano MD
-
Prognostic Implications of Quantitative Flow Ratio and Plaque Characteristics in Intravascular Ultrasound–Guided Treatment Strategy JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-07 You-Jeong Ki MD PhD, Jeehoon Kang MD, Jinlong Zhang MD PhD, Xinyang Hu MD PhD, Jun Jiang MD PhD, Joo-Yong Hahn MD PhD, Chang-Wook Nam MD PhD, Joon-Hyung Doh MD PhD, Bong-Ki Lee MD PhD, Weon Kim MD PhD, Jinyu Huang MD PhD, Fan Jiang MD PhD, Hao Zhou MD PhD, Peng Chen MD PhD, Lijiang Tang MD PhD, Wenbing Jiang MD PhD, Xiaomin Chen MD PhD, Wenming He MD PhD, Sung-Gyun Ahn MD PhD, Myeong-Ho Yoon MD PhD
Quantitative flow ratio (QFR) is a method for evaluating fractional flow reserve without the use of an invasive coronary pressure wire or pharmacological hyperemic agent. The aim of this study was to investigate the prognostic implications of QFR and plaque characteristics in patients who underwent intravascular ultrasound (IVUS)–guided treatment for intermediate lesions. Among the IVUS-guided strategy
-
First Experience With Amulet in the United States JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-02 Mohamad Alkhouli, James V. Freeman, Christopher R. Ellis, Atman P. Shah, Hemal Gada, Megan Coylewright, Monica Lo, Akash Makkar, Himanshu Agarwal, Dhanunjaya Lakkireddy
-
Transcatheter Pulmonary Valve Replacement With Balloon-Expandable Valves: Utilization and Procedural Outcomes From the IMPACT Registry JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-01-22 Ada C. Stefanescu Schmidt, Aimee K. Armstrong, Jamil A. Aboulhosn, Kevin F. Kennedy, Thomas K. Jones, Daniel S. Levi, Doff B. McElhinney, Ami B. Bhatt
-
Coronary Physiology by Different Approaches to Guide PCI: Adding Allies to Optimize Outcomes JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-01-22 Sergio Barrera, José M. de la Torre Hernández
-
Intravascular Imaging for PCI: Do Protocols Matter? JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-01-22 Gary S. Mintz
-
-
Transcatheter Pulmonary Valve Replacement: History Is on the Move JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-01-22 Sébastien Hascoet, Clément Karsenty, Alain Fraisse
-
Right Heart Reverse Remodeling and Prosthetic Valve Function After Transcatheter vs Surgical Pulmonary Valve Replacement JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-01-22 Alexander C. Egbe, Abdalla A. Salama, William R. Miranda, Snigdha Karnakoti, Jason H. Anderson, C. Charles Jain, Luke J. Burchill, Heidi M. Connolly
-
Pulmonary Valve Replacement: What Is the Best Way? JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-01-22 Michael Rahbek Schmidt, Mathis Gröning
-
Safety and Efficacy of Combining Left Atrial Appendage Occlusion With Another Cardiac Procedure JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-01-22 Mahmoud Ismayl, Hasaan Ahmed, James V. Freeman, Mohamad Alkhouli, Dhanunjaya Lakkireddy, Andrew M. Goldsweig
-
Two Are Better Than One: Are Concomitant Procedures the Future of Transcatheter Interventions? JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-01-22 Sameer Gafoor, Sidakpal S. Panaich
-
Intravascular Imaging-Guided Percutaneous Coronary Intervention Before and After Standardized Optimization Protocols JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-01-22 Woochan Kwon, David Hong, Ki Hong Choi, Seung Hun Lee, Doosup Shin, Jong-Young Lee, Seung-Jae Lee, Sang Yeub Lee, Sang Min Kim, Kyeong Ho Yun, Jae Young Cho, Chan Joon Kim, Hyo-Suk Ahn, Chang-Wook Nam, Hyuck-Jun Yoon, Yong Hwan Park, Wang Soo Lee, Taek Kyu Park, Jeong Hoon Yang, Seung-Hyuk Choi, Joo Myung Lee
-
TRANSFORM I: Knockout of Paclitaxel Over Sirolimus in Drug-Coated Balloons? JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-01-22 Iñigo Lozano, Juan Rondan, Jose M. Vegas
Abstract not available